# ARS Pharmaceuticals, Inc.: Form SC 13D, filed Nov 18, 2022

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: SC 13D
- Filed: 2022-11-18
- Accepted by EDGAR: Nov 18, 2022, 17:06 ET
- Period: not reported
- Accession: 0001193805-22-001578
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119380522001578/e618041_sc13d-arsp.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119380522001578/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119380522001578/e618041_sc13d-arsp.htm

Filed Nov 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001193805-22-001578. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
